Cetirizine Hydrochloride Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-05-29　·　258 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 2.4 Bn
2033 年預估規模: USD 3.9 Bn
年複合成長率 CAGR: 7.2%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-05-29頁數 258報告編號 CMI2069

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Cetirizine Hydrochloride Market, By Dosage Form (Tablet, Syrup, and Solution), By Age Group (Adult and Pediatric), By Application (Allergic Rhinitis, Allergic Conjunctivitis, Eczema, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Cetirizine hydrochloride is a second-generation histamine H1 antagonist that is effective in treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Cetirizine does not cause drowsiness or anticholinergic side effects opposed to conventional antihistamines. Cetirizine is available in various forms such as regular and chewable tablets, capsules, and solutions. Market Dynamics Increasing prevalence of allergic conditions in children and adult population is major factor driving growth of the cetirizine hydrochloride market. According to the National Health Interview Survey (NHIS), 2014, around 8.4% of children under the age of 18 suffered from hay fever, 10% from respiratory allergies, 5.4% from food allergies, and 11.6% from skin allergies in the U.S. Furthermore, allergic conjunctivitis imposes economic and social burden on the affected population, thereby increasing the adoption of efficient treatment to curb the increasing healthcare costs. According to the Department of Ophthalmology and Visual Sciences, University of Wisconsin, 2013, an estimated 6 million people are affected by bacterial conjunctivitis, annually in the U.S. The total expenditure in treatment of the disease was reported around US $377 million to US$ 857 million, annually. Key features of the study • This report provides in-depth analysis of the cetirizine hydrochloride market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by leading players • It profiles leading players in the global cetirizine hydrochloride market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans • Key companies covered as a part of this study include, Johnson and Johnson, Mylan, Inc., Nicox S.A., Strides Shasun, Apotex, Inc., Teva UK Limited, Aurobindo Pharma Limited, Jubilant Life Sciences, Tris Pharma, Inc., and Cipla Ltd. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics • The global cetirizine hydrochloride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cetirizine hydrochloride market Market Segmentation • By Dosage Form (Revenue, USD Bn, 2021-2033) o Tablet o Syrup o Solution • By Age Group (Revenue, USD Bn, 2021-2033) o Adult o Pediatric • By Application (Revenue, USD Bn, 2021-2033) o Allergic Rhinitis o Allergic Conjunctivitis o Eczema o Others • By Distribution Channel (Revenue, USD Bn, 2021-2033) o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • By Region (Revenue, USD Bn, 2021-2033) o North America  U.S.  Canada o Latin America  Brazil  Mexico  Argentina  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Spain  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  South Africa  Central Africa  North Africa • Key Players o Johnson and Johnson o Mylan, Inc. o Nicox S.A. o Strides Shasun o Apotex, Inc. o Teva UK Limited o Aurobindo Pharma Limited o Jubilant Life Sciences o Tris Pharma, Inc. o Cipla Ltd.

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Dosage Form  Market Snapshot, By Age Group  Market Snapshot, By Application  Market Snapshot, By Distribution Channel  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Key Developments o Product Approval o Collaboration/Merge/Acquisition o Regulatory Landscape o PEST Analysis o Porter’s Five Forces Analysis o Epidemiology o Robust Pipeline Analysis 4. Global Cetirizine Hydrochloride Market, By Dosage Form, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Tablet  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Syrup  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Solution  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) 5. Global Cetirizine Hydrochloride Market, By Age Group, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Adult  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Pediatric  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) 6. Global Cetirizine Hydrochloride Market, By Application, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Allergic Rhinitis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Allergic Conjunctivitis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Eczema  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) 7. Global Cetirizine Hydrochloride Market, By Distribution Channel, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Hospital Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Retail Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Online Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) 8. Global Cetirizine Hydrochloride Market, By Region, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2022–2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Billion) o North Africa o Central Africa o South Africa 9. Competitive Landscape o Heat Map Analysis o Market Share Analysis o Company Profile  Johnson and Johnson o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Mylan, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Nicox S.A. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Strides Shasun o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Apotex, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Teva UK Limited o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Aurobindo Pharma Limited o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Jubiliant Life Sciences o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Tris Pharma, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Cipla Ltd. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies o Analyst Views 10. Section o References o Research Methodology o About Us

提及公司

Johnson and JohnsonMylan, Inc.Nicox S.A.Strides ShasunApotex, Inc.Teva UK LimitedAurobindo Pharma LimitedJubilant Life SciencesTris Pharma, Inc.Cipla Ltd.

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們